Drug Discovery, Development and Delivery: Current Status and Future Perspectives
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Drug Discovery, Development and Delivery".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 56
Special Issue Editors
2. Comprehensive Cancer Center François Baclesse, UNICANCER, 14076 Caen, France
Interests: drug discovery; drug development; drug delivery; computational drug design (CADD); medicinal chemistry; natural products; cancer therapeutics; infectious diseases
Interests: medicinal chemistry; organic synthesis; natural products; drug design in antiviral and anticancer agents; molecular dynamics; GPER; estrogen receptors; breast cancer; curcumin
Special Issue Information
Dear Colleagues,
Biomedicines is excited to announce a new Special Issue, entitled "Drug Discovery, Development and Delivery: Current Status and Future Perspectives".
Guest-edited by Dr. Shafi Ullah Khan and Dr. Thet Thtet Htar, a medicinal chemist and computational drug discovery professional, respectively, this Special Issue aims to explore the groundbreaking advancements fundamentally reshaping the future of medicine. We seek contributions that highlight the synergistic integration of cutting-edge computational and experimental methodologies to accelerate the discovery, optimization, and characterization of novel therapeutic agents. This encompasses innovative approaches in computer-aided drug design (CADD), the transformative power of machine learning (ML) and artificial intelligence (AI) for predicting drug properties, and sophisticated experimental techniques for drug synthesis, characterization, and biological evaluation.
A core focus is on how these diverse strategies can be leveraged to effectively overcome critical challenges, particularly addressing resistance mechanisms and the complexities of diseases that impact millions globally. We invite research, as well reviews, on patient-centric therapies for a wide range of conditions, including various cancers, resistant infectious diseases, and neurodegenerative conditions like Alzheimer's, along with cardiovascular diseases. Submissions encompassing both synthetic compounds and promising natural products are highly encouraged.
Dr. Shafi Ullah Khan
Dr. Thet Thet Htar
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug discovery
- rational drug design
- computer-aided drug design (CADD)
- drug repurposing
- artificial intelligence (AI) and machine learning (ML)
- cancer therapeutics
- infectious diseases
- natural products
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
